Maximum quantity allowed is 999
Please select the quantity
CAS RN: 154598-52-4 | Product Number: E0997
Efavirenz
×
Purity: >98.0%(HPLC)(N)
Synonyms:
- (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 5G |
$87.00
|
7 | 13 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
| Product Number | E0997 |
Purity / Analysis Method 
|
>98.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | C__1__4H__9ClF__3NO__2 = 315.68 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Frozen (<0°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 154598-52-4 |
| Reaxys Registry Number | 7387333 |
| PubChem Substance ID | 253660107 |
| Merck Index (14) | 3521 |
| MDL Number | MFCD05662344 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 98.0 % |
| Melting point | 136.0 to 140.0 °C |
| Specific rotation [a]20/D | -93.0 to -98.0 deg(C=1,MeOH) |
Properties (reference)
| Melting Point | 138 °C |
| Specific Rotation | -95° (C=1,MeOH) |
| Maximum Absorption Wavelength | 247 nm (MeOH) |
| Solubility in water | Insoluble |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. H413 : May cause long lasting harmful effects to aquatic life. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| RTECS# | DM3440000 |
Transport Information:
| H.S.code* | 2934.99-000 |
Application
Efavirenz: a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Efavirenz is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) which shows good inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT). RT is an essential viral enzyme which transcribes viral RNA into DNA. Compared with first-generation NNRTIs such as nevirapine [N0922], efavirenz shows greater resilience to drug resistance mutations within HIV-1 RT. Efavirenz is not effective against HIV-2 RT and human DNA polymerase.
References
- Efavirenz
- Structural Basis for the Resilience of Efavirenz (DMP-266) to Drug Resistance Mutations in HIV-1 Reverse Transcriptase
- The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism:Implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity
- Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance
- The history of antiretrovirals: key discoveries over the past 25 years
PubMed Literature
Documents
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.